Co-Authors
This is a "connection" page, showing publications co-authored by Rifat Hamoudi and Qutayba Hamid.
Connection Strength
1.285
-
Current Status of Baricitinib as a Repurposed Therapy for COVID-19. Pharmaceuticals (Basel). 2021 Jul 15; 14(7).
Score: 0.239
-
Systems Immunology Analysis Reveals the Contribution of Pulmonary and Extrapulmonary Tissues to the Immunopathogenesis of Severe COVID-19 Patients. Front Immunol. 2021; 12:595150.
Score: 0.238
-
Insight into molecular mechanisms underlying hepatic dysfunction in severe COVID-19 patients using systems biology. World J Gastroenterol. 2021 Jun 07; 27(21):2850-2870.
Score: 0.237
-
Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19. Front Physiol. 2020; 11:555039.
Score: 0.226
-
Enhanced Expression of Autoantigens During SARS-CoV-2 Viral Infection. Front Immunol. 2021; 12:686462.
Score: 0.060
-
SARS-CoV-2 Switches 'on' MAPK and NF?B Signaling via the Reduction of Nuclear DUSP1 and DUSP5 Expression. Front Pharmacol. 2021; 12:631879.
Score: 0.059
-
Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection. Mol Ther Methods Clin Dev. 2021 Mar 12; 20:109-121.
Score: 0.057
-
Multiple early introductions of SARS-CoV-2 into a global travel hub in the Middle East. Sci Rep. 2020 10 20; 10(1):17720.
Score: 0.057
-
Effect of Common Medications on the Expression of SARS-CoV-2 Entry Receptors in Kidney Tissue. Clin Transl Sci. 2020 11; 13(6):1048-1054.
Score: 0.056
-
Cardiovascular medications and regulation of COVID-19 receptors expression. Int J Cardiol Hypertens. 2020 Sep; 6:100034.
Score: 0.055